The Latest Breaking News from Novavax

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

One company developing a vaccine for covid issued a statement of uncertainty that spooked investors.

Stocks nudge higher on strong China data after February slump; Novavax plunges as vaccine maker casts doubt on company's future; HP shares get boost from solid profit outlook, cost-cutting; Lowe's earnings on deck after muted Home Depot spending outlook and Salesforce earnings to highlight extent of activist pressure on CEO…

Washington (AFP) - Covid-19 vaccine maker Novavax raised doubts Tuesday about its ability to continue its business, announcing plans to cut spending after struggles in rolling out its coronavirus jab.

Novavax says there's "substantial doubt" regarding its ability to continue, and NVAX stock crashed Wednesday.

FDA expert committee needs more data to decide when to give out COVID boosters — and who needs them most

Novavax plans to update its Covid vaccine for new variants, and NVAX stock outperformed its vaccine stock rivals.

At a meeting to simplify the nation’s COVID-19 vaccination policy, the FDA’s panel of experts could agree on only one thing: Information is woefully lacking about how often different groups of Americans need to be vaccinated. That data gap has contributed to widespread skepticism, undervaccination, and ultimately unnecessary deaths from…

Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters going forward, but some expressed skepticism about whether all Americans need to receive the shots annually.

Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.